Tofacitinib-induced progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome
- PMID: 37306796
- DOI: 10.1007/s10072-023-06897-4
Tofacitinib-induced progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome
References
-
- Tan CS, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9(4):425–437. https://doi.org/10.1016/S1474-4422(10)70040-5 - DOI - PubMed - PMC
-
- Wathes R, Moule S, Milojkovic D (2013) Progressive multifocal leukoencephalopathy associated with ruxolitinib. N Engl J Med 369(2):197–198. https://doi.org/10.1056/NEJMc1302135 - DOI - PubMed
-
- Kucharz EJ, Stajszczyk M, Kotulska-Kucharz A, Batko B, Brzosko M, Jeka S, Leszczyński P, Majdan M, Olesińska M, Samborski W, Wiland P (2018) Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology. Reumatologia 56(4):203–211. https://doi.org/10.5114/reum.2018.77971 - DOI - PubMed - PMC
-
- Yun J, Osehobo E, Lawson EC, Harrison T, Harrison A (2022) Tofacitinib-induced progressive multifocal leukoencephalopathy with immune reconstitution inflammatory syndrome. Clin Neurol Neurosurg 214:107143. https://doi.org/10.1016/j.clineuro.2022.107143 - DOI - PubMed
-
- Fournier A, Martin-Blondel G, Lechapt-Zalcman E, Dina J, Kazemi A, Verdon R, Mortier E, de La Blanchardière A (2017) Immune reconstitution inflammatory syndrome unmasking or worsening AIDS-related progressive multifocal leukoencephalopathy: a literature review. Front Immunol 23(8):577. https://doi.org/10.3389/fimmu.2017.00577 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
